43
https://pubmed.ncbi.nlm.nih.gov/38093299
Early-life exposure to the cyanotoxin Microcystin-LR causes hepatic inflammation and progression of metabolic dysfunction associated steatotic liver disease by disrupting the gut microbiome and inhibiting NLRP3 inflammasome activation, indicating potential therapeutic targets in gut dysbiosis and NLRP3 inflammasome activation for toxin-associated inflammatory liver diseases.
